Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Familial ependymoma × Amplified Fragment Length Polymorphism Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Accelerated Phase 2 Immunoblastic Lymphadenopathy 2 Congenital Abnormalities 2 Breast Neoplasms 2 Thrombocytopenia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1

Interventions

Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 ribociclib 1 palbociclib 1 olaparib 1 etoposide phosphate 1 erdafitinib 1 X-Rays 1 Sunitinib 1 Specimen Handling 1 Radiotherapy 1 Phantoms, Imaging 1 Nuclear Medicine Department, Hospital 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Microarray Analysis 1 Lapatinib 1 Irinotecan 1 Immunologic Techniques 1 Immunohistochemistry 1 Immunoglobulin G 1 Ifosfamide 1 Fluorodeoxyglucose F18 1 Etoposide 1 Donepezil 1 Disulfides 1 Dasatinib 1 Cyproheptadine 1 Carboplatin 1 Blotting, Western 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡